Cholestasis in adults (raised ALP and GGT)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Fever, chills, jaundice, dilated bile ducts: emergency
- No tests in the community: refer the same day (emergency department, gastroenterologist).
- Warning signs: fever with rigors or right upper quadrant pain (cholangitis), unexplained jaundice, confusion, dilated bile ducts on ultrasound.
Cholestasis without emergency signs: ultrasound and first tests
- Abdominal ultrasound (not a laboratory test), first.
Fasting laboratory tests
- Alkaline phosphatase, GGT, total and conjugated bilirubin, AST, ALT
- Antimitochondrial antibodies
- Antinuclear antibodies on HEp-2 cells (rim-like or multiple nuclear dots pattern)if needednon-French guidelineImmediately, with anti-mitochondrial antibodies: EASL 2017 recommends looking for both in any patient with unexplained cholestasis [5]. Otherwise, they are requested if anti-mitochondrial antibodies are negative (next tab).
- IgM
- PT (if jaundice or prolonged cholestasis)if needednon-French guidelineJaundice or chronic cholestasis: PT may lengthen through vitamin K deficiency (fat malabsorption) [4].
- Hepatitis B serologyif needednon-French guidelineMixed pattern (raised transaminases), viral risk factor (country of origin, drug use): viral hepatitis can be cholestatic and is part of the basic aetiological work-up of the BSG [2,4].
- Hepatitis C serologyif needednon-French guidelineMixed pattern (raised transaminases), viral risk factor (country of origin, drug use): viral hepatitis can be cholestatic and is part of the basic aetiological work-up of the BSG [2,4].
- β-hCG (woman of childbearing potential)if needednon-French guidelineWoman of childbearing potential: look for pregnancy and intrahepatic cholestasis of pregnancy (pruritus in the 2nd and 3rd trimesters) [2,6].
Intrahepatic cholestasis, negative antimitochondrial antibodies
Laboratory tests
- Antinuclear antibodies on HEp-2 cells (rim-like or multiple nuclear dots pattern)
- IgG
- ANCA (if inflammatory bowel disease or suspected sclerosing cholangitis)if neededAssociated IBD, young man, biliary-type flares: pointer to primary sclerosing cholangitis; p-ANCA poorly specific, especially in IBD [7].
- IgA anti-tissue transglutaminase antibodies (tTG-IgA)if neededSuspected primary sclerosing cholangitis: possible association with coeliac disease, looked for by the AFEF in the initial work-up [7].
- Total IgAif neededSuspected primary sclerosing cholangitis: possible association with coeliac disease, looked for by the AFEF in the initial work-up [7].
- Anti-smooth muscle antibodies (if unexplained intrahepatic cholestasis)if needednon-French guidelineUnexplained intrahepatic cholestasis with negative anti-mitochondrial antibodies: the ACG (2017) looks for anti-smooth muscle antibodies together with anti-mitochondrial and antinuclear antibodies (primary biliary cholangitis, autoimmune cholangiopathy) [6], and the BSG includes them in the aetiological work-up of any abnormal liver test [4]; with markedly raised transaminases or IgG, they help to identify an associated autoimmune hepatitis [9].
- MR cholangiography (not a laboratory test): most often prescribed by the hepatologist.
Sources (12)
- Donnan PT, McLernon D, Dillon JF, et al. Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE). Health Technol Assess. 2009;13(25):iii-iv, ix-xi, 1-134.
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237-67.
- Maffei M, Hadengue A. Cholestase de l'adulte. 1. Démarche diagnostique. Rev Med Suisse. 2006;2(77):1960-4.
- Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests (British Society of Gastroenterology). Gut. 2018;67(1):6-19.
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145-172.
- Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18-35.
- Association française pour l'étude du foie (AFEF). Recommandations pour le diagnostic et le suivi non-invasif des maladies chroniques du foie. Juillet 2020. Chapitre 6 : cholangite biliaire primitive (C. Corpechot) ; chapitre 7 : cholangite sclérosante primitive (O. Chazouillères).
- Hirschfield GM, Dyson JK, Alexander GJM, et al. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 2018;67(9):1568-1594.
- Chapman MH, Thorburn D, Hirschfield GM, et al. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019;68(8):1356-1378.
- Lindor KD, Kowdley KV, Harrison ME. ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol. 2015;110(5):646-659.
- ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit FURADANTINE 50 mg (nitrofurantoïne), gélule, rubrique 4.8.
- ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit CAPTOPRIL EG 25 mg, comprimé (captopril), rubrique 4.8.